Remove 2007 Remove Compliance Remove COVID-19 Remove FDA
article thumbnail

3 Lessons Learned from Pandemic-Era Clinical Development Regulatory Practices

HIT Consultant

Ronan Brown, SVP and Head of Integrated Global Compliance, IQVIA. The world has been in urgent need of COVID-19 vaccines, treatments, and diagnostic tools. Here’s a look at what we’ve learned from COVID-19 era regulatory practices in clinical development.

article thumbnail

SQA Regulatory Surveillance Summary | Monthly Update 2023 – May And June

SQA

Experience with large-scale events such as Hurricane Maria and the COVID-19 pandemic, and more recent geopolitical events, have cast a wider lens on global supply chain and distribution vulnerabilities. TR 43 was originally published in 2007 and revised in 2013 to address industry feedback. cosmetic regulatory framework.

FDA 40